assurance courtage
How insurance specialists can package one Solvency UK asset or reporting decision, then build recurring Matching Adjustment and data assurance.
How do these four analyses build a market view?
Each window links an official source to the entities involved, the attributes that change the decision, the evidence required and the acquisition channels to test. The sector page moves from regulatory signal to opportunity portfolio without confusing developed potential with confidential results.
Health insurance 2024: how did remuneration caps and outreach rules change acquisition?
How the Swiss rules 2024 on remuneration and unsolicited calling had reclassified the acquisition channels in health insurance.
ISA 2024: how did supervision reform change insurance intermediation?
How ISA 2024 had expanded surveillance of intermediaries and shifted trust toward status, organization, and evidence.
ICA 2022: how did the revision change the explanation of insurance contracts?
How the revision of ICA which came into force in 2022 had shifted the value towards rights, prescription and a lasting explanation.
Does your market present a comparable window?
The eligibility report dates and quantifies it, then tests whether it deserves action.
What you will be able to decide
The topic is broken down into entities, attributes, evidence, channels, costs and decision points. Institutions are cited in the text; no external resource interrupts the reading path.
Where is the next buying decision taking shape?
An investment team may see a long-dated asset that fits an insurer’s liabilities, while risk, actuarial, finance and regulatory teams see four different versions of the same cash flows. Solvency UK widened parts of the Matching Adjustment opportunity and streamlined some permission routes, but it also strengthened responsibility for asset eligibility, internal credit assessment, attestation and portfolio data. The commercial opening is therefore not “released capital”. It is a controlled decision on one asset, portfolio change or reporting problem whose evidence is not yet coherent. This reading explains how an insurance, actuarial or data specialist can package a bounded decision sprint, translate Matching Adjustment mechanics into plain commercial questions, build a traceable evidence room and create recurring assurance around attestation, the Matching Adjustment Asset and Liability Information Return and policy change. It treats PRA permission, prudence and capital effects as decisions for the authorised insurer—not promises a campaign can make.
…
Turn a market change into qualified demand.
A claims portal returns in forty minutes, yet vulnerable customers wait two days for a manual workaround. A cloud supplier passes its own test, yet nobody can show how the insurer’s customer service stays within tolerance when the dependency fails. Those are not technology anecdotes. They are decision gaps with an owner, evidence and a commercial consequence. The 31 March 2025 milestone required firms in scope to complete the mapping and testing needed to remain within impact tolerances for each important business service. It did not close the market. It moved the buying question from “Are we ready for the deadline?” to “Can the board still prove this service works after the last product, supplier, incident or operating-model change?” This reading explains who is in scope, how to distinguish a customer service from its systems, what a useful review should deliver, and how an adviser can turn recurring evidence gaps into a bounded first engagement and an ongoing resilience service.
4 readings · assurance courtage
Does your market present a comparable window?
The eligibility report dates and quantifies it, then tests whether it deserves action.
Test my eligibility